Prophylactic antiviral therapy for hepatitis B virus surface antigen‐positive patients with diffuse large B‐cell lymphoma treated with rituximab‐containing chemotherapy-Reference-Cited by-同舟云学术

Prophylactic antiviral therapy for hepatitis B virus surface antigen‐positive patients with diffuse large B‐cell lymphoma treated with rituximab‐containing chemotherapy

Published:2021-03-18 Issue:5 Volume:112 Page:1943-1954
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Yamauchi Nobuhiko¹,Maruyama Dai²^ORCID,Choi Ilseung³,Atsuta Yoshiko⁴,Sakai Rika⁵,Miyashita Kazuho⁶,Moriuchi Yukiyoshi⁷,Tsujimura Hideki⁸,Kubota Nobuko⁹,Yamamoto Go¹⁰,Igarashi Tadahiko¹¹,Izutsu Koji²,Yoshida Shinichiro¹²,Kojima Kensuke¹³,Uchida Toshiki¹⁴,Inoue Yoshiko¹⁵,Tsukamoto Norifumi¹⁶,Ohtsuka Eiichi¹⁷,Suzuki Sachiko¹⁸,Inaguma Yoko¹⁹,Ichikawa Satoshi²⁰,Gomyo Hiroshi²¹,Ushijima Yoko²²,Nosaka Kisato²³^ORCID,Kurata Mio⁴,Tanaka Yasuhito²⁴²⁵,Ueda Ryuzo²⁶,Mizokami Masashi²⁷,Kusumoto Shigeru²⁸^ORCID

Affiliation:

1. Department of Hematology National Cancer Center East Hospital Kashiwa Japan

2. Department of Hematology National Cancer Center Hospital Tokyo Japan

3. Department of Hematology National Hospital Organization Kyushu Cancer Center Fukuoka Japan

4. Japanese Data Center for Hematopoietic Cell Transplantation Nagoya Japan

5. Department of Hematology and Medical Oncology Kanagawa Cancer Center Yokohama Japan

6. Department of Hematology Yokohama City University Medical Center Yokohama Japan

7. Department of Hematology Sasebo City General Hospital Sasebo Japan

8. Division of Hematology‐Oncology Chiba Cancer Center Chiba Japan

9. Department of Hematology Saitama Cancer Center Saitama Japan

10. Department of Hematology Toranomon Hospital Tokyo Japan

11. Department of Hematology Gunma Prefectural Cancer Center Gunma Japan

12. Department of Hematology National Hospital Organization Nagasaki Medical Center Ohmura Japan

13. Division of Hematology, Respiratory Medicine and Oncology Department of Internal Medicine Faculty of Medicine Saga University Saga Japan

14. Department of Hematology and Oncology Japanese Red Cross Nagoya Daini Hospital Nagoya Japan

15. Department of Hematology National Hospital Organization Kumamoto Medical Center Kumamoto Japan

16. Department of Hematology Gunma University Hospital Maebashi Japan

17. Department of Hematology Oita prefectural Hospital Oita Japan

18. Department of Hematology National Hospital Organization Hokkaido Cancer Center Sapporo Japan

19. Division of Hematology Fujita Health University Toyoake Japan

20. Hematology and Rheumatology Tohoku University Graduate School of Medicine Sendai Japan

21. Division of Hematology Hyogo Cancer Center Akashi Japan

22. Hematology and Oncology Nagoya University Graduate School of Medicine Nagoya Japan

23. Department of Hematology Kumamoto University Hospital Kumamoto Japan

24. Department of Virology and Liver unit Nagoya City University Graduate School of Medical Sciences Nagoya Japan

25. Department of Gastroenterology and Hepatology Faculty of Life Sciences Kumamoto University Kumamoto Japan

26. Department of Tumor Immunology Aichi Medical University School of Medicine Nagakute Japan

27. Genome Medical Sciences Project National Center for Global Health and Medicine Ichikawa Japan

28. Department of Hematology and Oncology Nagoya City University Graduate School of Medical Sciences Nagoya Japan

Funder

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.14846

Reference25 articles.

1. Management of patients with hepatitis B who require immunosuppressive therapy

2. Reactivation of hepatitis B virus following systemic chemotherapy for malignant lymphoma

3. Hepatitis B Virus Reactivation in Lymphoma Patients With Prior Resolved Hepatitis B Undergoing Anticancer Therapy With or Without Rituximab

4. Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: Analysis from the Asia Lymphoma Study Group

5. CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcome of Multiple Myeloma Patients With Hepatitis B Surface Antigen: Korean Multiple Myeloma Working Party 2103 Study;Clinical Lymphoma Myeloma and Leukemia;2024-02

2. Hepatitis B virus–associated diffuse large B cell lymphoma: epidemiology, biology, clinical features and HBV reactivation;Holistic Integrative Oncology;2023-10-20

3. HBV-associated DLBCL of poor prognosis: advance in pathogenesis, immunity and therapy;Frontiers in Immunology;2023-07-07

4. Management of Hepatitis B Virus Reactivation after the Completion of Cancer Chemotherapy using a Plan-do-Check-Act Cycle;Journal of Cancer Research Updates;2022-11-02

5. Expression of PD-L1 and YWHAZ in Patients with Diffuse Large B Cell Lymphoma: A Possible Association with the Prognosis of Lymphoma;Journal of Immunology Research;2022-09-28